The halo-artifact leading to a potential false negative result of 68Ga-PSMA PET-CT. A case report. (#73)
68Ga-PSMA is a highly promising tracer for the evaluation of patients with prostate cancer. It has been demonstrated a high detection rate and specificity of 68Ga-PSMA PET-CT in the diagnosis of tumor recurrence after prostatectomy, radiotherapy or other local treatment modalities.
More recently, PET-MR hybrid systems have been evaluated in prostate cancer biochemical recurrence using 68Ga-PSMA. In a significant number of patients, an artifact of reduced PET signal ("halo") around the bladder and/or kidney led to limitations concerning visualization of prostate cancer local recurrence or metastasis. Interestingly, this photopenic artifact was described in PET-MR but not in PET-CT imaging.
We report a case of recurrent prostate cancer evaluated by 68Ga- PMSA PET-CT in which most of the metastatic lymph nodes were missed by the images performed 1 hour after tracer injection due to the halo-artifact and were correctly detected in the PET-CT images obtained 2 hours after injection.
This report demonstrates that halo-artifact which occurs in 68GaPSMA PET/CT must be recognized in order to reduce the possibility of a false-negative diagnosis of recurrent prostate cancer.
- Afshar-Oromich A., Haberkorn,U., Schlemmer H.P., Fenchel M., Eder M. et al. Comparison of PET-CT and PET-MR hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging (2014) 41:887-97.